{
    "organizations": [],
    "uuid": "eae711ec1e7b03479dc57c78000316ef707332e6",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-richters-esmya-has-favourable-bene/brief-richters-esmya-has-favourable-benefit-risk-balance-ema-idUSB3N1IK02Q",
    "ord_in_thread": 0,
    "title": "BRIEF-Richter's Esmya has favourable benefit-risk balance - EMA",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 21 (Reuters) - European Medicines Agency (EMA) says in Assessment report on provisional measures about uterine fibrosis drug of Hungary’s Richter:\n* RICHTER‘S ESMYA UTERINE FIBROSIS DRUG‘S BENEFIT-RISK BALANCE “REMAINS FAVOURABLE SUBJECT TO THE AGREED PROVISIONAL MEASURES”\n* EMA RECOMMENDS VARIATIONS OF THE TERMS OF THE MARKETING AUTHORISATION FOR ESMYA\n* EMA COMMITTEE SAYS RECOMMENDATION IS WITHOUT PREJUDICE TO THE FINAL CONCLUSIONS OF ONGOING PROCEDURE REGARDING ESMYA Source text for Eikon: [ here ] Further company coverage: (Reporting by Marton Dunai)\n ",
    "published": "2018-02-21T23:15:00.000+02:00",
    "crawled": "2018-02-22T17:58:51.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "european",
        "medicine",
        "agency",
        "ema",
        "say",
        "assessment",
        "report",
        "provisional",
        "measure",
        "uterine",
        "fibrosis",
        "drug",
        "hungary",
        "richter",
        "richter",
        "esmya",
        "uterine",
        "fibrosis",
        "drug",
        "balance",
        "remains",
        "favourable",
        "subject",
        "agreed",
        "provisional",
        "measure",
        "ema",
        "recommends",
        "variation",
        "term",
        "marketing",
        "authorisation",
        "esmya",
        "ema",
        "committee",
        "say",
        "recommendation",
        "without",
        "prejudice",
        "final",
        "conclusion",
        "ongoing",
        "procedure",
        "regarding",
        "esmya",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "reporting",
        "marton",
        "dunai"
    ]
}